Skin Cancer

New Recommendations Target Promoting Better Sun Protection Habits for All Patients

New Recommendations Target Promoting Better Sun Protection Habits for All Patients

By

A new US Preventive Services Task Force Evidence Report is suggesting that greater efforts are needed to educate children and young adults with fair skin about risks of sun exposure. Although the Task Force recommendations are directed at primary care, its members are encouraging oncology nurses to take note of these new findings.

What Prompts Indoor Tanners and Nontanners to Undergo Skin Cancer Screening?

What Prompts Indoor Tanners and Nontanners to Undergo Skin Cancer Screening?

By

Researchers sought to determine the factors that influenced a decision to undergo skin cancer screening among more than 30,000 adults who have ever used an indoor tanning device and nontanners.

Study Determined Association Between Risk of Melanoma, Aspirin Use

Study Determined Association Between Risk of Melanoma, Aspirin Use

By

In a review of nearly 200,000 patients from a Midwest metropolitan area, researchers sought to determine if chronic aspirin use would offer the same risk reduction for melanoma as has been seen in various cancers.

Prognostic Indicator for Cutaneous Melanoma: SNLB vs Breslow Thickness

Prognostic Indicator for Cutaneous Melanoma: SNLB vs Breslow Thickness

By

Investigators sought to compare the prognostic value of sentinel lymph node status vs Breslow thickness in patients with cutaneous melanoma.

USPSTF: Skin Cancer Counseling Recommended for Fair-Skinned Individuals

USPSTF: Skin Cancer Counseling Recommended for Fair-Skinned Individuals

The U.S Preventive Services Task Force recommends counseling for fair-skinned individuals younger than 24 years, and selective counseling is recommended for adults.

USPSTF: Behavioral interventions do not reduce sunburn or skin cancer outcomes

1. Behavioral interventions increase sun protection behavior but do not reduce sunburn or skin cancer outcomes. 2. Behavior interventions lead to increased skin self-examinations but may lead to additional skin procedures without finding additional skin cancers. Evidence Rating Level: 1 (Excellent) Study Rundown: While melanoma comprises 2% of all skin cancers, it causes more than []

Presence of Iris Pigmented Lesions Indicates Melanoma Risk

Presence of Iris Pigmented Lesions Indicates Melanoma Risk

By

The likelihood for development of cutaneous melanoma may be greater for individuals with iris pigmented lesions, according to a study.

Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC 

Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC 

By

AJCC8 tumor classification demonstrated significantly superior homogeneity and monotonicity to AJCC7 tumor classification.

Age Not a Deterrent to Immunotherapy for Malignant Melanoma

Age Not a Deterrent to Immunotherapy for Malignant Melanoma

By

Investigators sought to evaluate whether age is associated with risk for immune-related adverse events among patients with metastatic melanoma treated with immunotherapy.

Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma

Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma

By

Researchers report on finding of a double-blind phase 3 study on the efficacy of adjuvant vemurafenib in patients with resected stage IIC to IIIB melanoma.

Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma

Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma

By

A retrospective study evaluated the relationship of BMI with survival outcomes among patients with metastatic melanoma who received targeted therapy, immunotherapy, or chemotherapy.

FDA Upgrades Nivolumab to Regular Approval for Adjuvant Treatment of Advanced Melanoma

FDA Upgrades Nivolumab to Regular Approval for Adjuvant Treatment of Advanced Melanoma

By

The FDA granted approval for nivolumab for adjuvant treatment of some patients with melanoma, based on the results of the CHECKMATE-238 study.

Potential for Metastatic Melanoma Cure Seen in High CR Rate With Pembrolizumab

Potential for Metastatic Melanoma Cure Seen in High CR Rate With Pembrolizumab

By

Baseline tumor size and PD-L1 status were independently associated with the likelihood of a complete response.

Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma

Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma

By

Patients presenting with lesions with shiny white streaks on dermoscopy should undergo biopsy for possible melanoma.

Adherence to Skin Cancer Screening Guidelines Beneficial in Management SCC in SOTRs

Adherence to Skin Cancer Screening Guidelines Beneficial in Management SCC in SOTRs

By

Transplant recipients developed squamous cell carcinomas that did not appear to behave more aggressively than those that developed in the immunocompetent group.

Fluorouracil Associated With Reduced Surgery for Squamous Cell Carcinoma

Fluorouracil Associated With Reduced Surgery for Squamous Cell Carcinoma

A reduced risk of squamous cell carcinoma, but not basal cell carcinoma, was observed for one year in at-risk individuals treated with fluorouracil.

Atopic Dermatitis Linked to Increased Risk of Skin Cancer

Atopic Dermatitis Linked to Increased Risk of Skin Cancer

Individuals with a history of atopic dermatitis have a higher risk of squamous cell carcinoma development, research indicates.

No Increased Risk for Melanoma in Patients With MM

No Increased Risk for Melanoma in Patients With MM

By

An increased prevalence of melanoma has been observed in patients with various immunocompromised conditions.

Researchers Find No Link Between Acne and Malignant Melanoma in Men

Researchers Find No Link Between Acne and Malignant Melanoma in Men

By

Individuals categorized as overweight or obese had a significantly increased risk for malignant melanoma.

Survival Benefit in Advanced Melanoma With Pembrolizumab Versus Ipilimumab

Survival Benefit in Advanced Melanoma With Pembrolizumab Versus Ipilimumab

By

Fifty-five percent of patients treated with pembrolizumab survived through 24-months compared with 43% of patients treated with ipilimumab.

Challenging the Standard of Care in Advanced Melanoma: Focus on Pembrolizumab

Challenging the Standard of Care in Advanced Melanoma: Focus on Pembrolizumab

[Cancer Management and Research] This study examines the advances that pembrolizumab has made in melanoma and upcoming research that may further improve melanoma treatment.

Is This the End of Cytotoxic Chemotherapy in Merkel Cell Carcinoma?

Is This the End of Cytotoxic Chemotherapy in Merkel Cell Carcinoma?

[OncoTargets and Therapy] A review of the role of chemotherapy in the treatment of Merkel cell carcinoma in view of the recent FDA approval of the PD-L1 antibody avelumab and limited and controversial data on the efficacy of chemotherapy in this disease.

Overall Survival in Advanced Melanoma Improved With Nivolumab, Ipilimumab Combination

Overall Survival in Advanced Melanoma Improved With Nivolumab, Ipilimumab Combination

By

Overall survival was significantly prolonged in patients with advanced melanoma who were treated with nivolumab plus ipilimumab compared with either drug alone, according to results from the Checkmate 067 study.

Skin Cancer Prevention Strategies Lacking in Work Settings

Skin Cancer Prevention Strategies Lacking in Work Settings

High occupational UV exposure tied to two-fold increase in skin cancer risk, but prevention strategies in work environments are often underutilized.

Awareness of Genomic Risk for Melanoma May Increase Conversations With Family, Health Care Providers

Awareness of Genomic Risk for Melanoma May Increase Conversations With Family, Health Care Providers

By

Awareness of personal genetic risk for melanoma may prompt patients to discuss cancer risk with family and health care professionals, and make lifestyle changes.

Risk of Nonmelanoma Skin Cancers Increased With Alcohol Consumption

Risk of Nonmelanoma Skin Cancers Increased With Alcohol Consumption

By

Researchers found that an association between alcohol consumption and nonmelanoma skin cancers may be dose-dependent. This risk includes basal cell carcinoma and cutaneous squamous cell carcinoma.

FDA Expands Ipilimumab Indication to Include Pediatric Unresectable or Metastatic Melanoma

FDA Expands Ipilimumab Indication to Include Pediatric Unresectable or Metastatic Melanoma

By

The FDA approved the indication expansion for ipilimumab based on evidence from 2 clinical trials evaluating its safety and efficacy in pediatric patients.

Adjuvant Bevacizumab Does Not Increase Survival in High-Risk Melanoma

Adjuvant Bevacizumab Does Not Increase Survival in High-Risk Melanoma

By

Five-year survival rate found similar to observation despite a significant improvement in disease-free interval.

Carvedilol, Some Beta Blockers Prevent UVB-induced Skin Cancer

Carvedilol, Some Beta Blockers Prevent UVB-induced Skin Cancer

By

A common beta blocker, carvedilol, is found to have preventive properties against the sun-induced cell damage that leads to skin cancer.

Noninvasive 2-Gene Test Helps Distinguish Melanoma From Nonmelanoma

Noninvasive 2-Gene Test Helps Distinguish Melanoma From Nonmelanoma

By

Two-gene pigmented lesion test classifies skin lesions as melanoma or nonmelanoma, helping with diagnostic challenges faced with the visual image and pattern recognition approach.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs